期刊文献+

蛋白质芯片技术检测血清室间隔缺损特异标志物的研究

Detection of serum biomarkers from isolated ventricular septal defect with protein chip technology.
下载PDF
导出
摘要 目的应用蛋白质芯片技术筛选单纯性室间隔缺损血清特异标志物。方法采用病例对照设计,用CM10蛋白质芯片检测56例单纯性室间隔缺损患儿与85例儿科常见病患儿血清,筛选血清差异蛋白。结果有21个蛋白具有统计学差异,其中质荷比6640.784、8571.079、6441.972、8698.804、3322.549、2128.960、2291.255、2055.652、2243.846和2.99.661等10个蛋白在VSD患儿血清中呈高表达,而质荷比2050.946、9306.537、7783.535、9198.666、2143.745、4604.572、7993.109、2824.602、2230.218、2083.311和9360.675等11个蛋白下调。结论蛋白质芯片技术是进行室间隔缺损分子流行病学研究的有效工具,所筛选出的蛋白成分可能是单纯性室间隔缺损的血清标志物。 Objectlve To screen serum biomarkers from sera of ventrieular septal defect (VSD) children by using proteinChip. Methods With a case - control design, serum samples from 56 isolated VSD patients and 85 patients with common pediatric diseases were detected with CM10 ProteinChip for the protein biomarkers that were significantly different from that in sera of VSD children and control. Results The contents of 21 proteins were significantly different from that of sera of VSD children and controls. Ten of the 21 proteins with the mass/charge (m/z) of 6640.784, 8571.079, 6441.972, 8698.804, 3322.549, 2128.960, 2291. 255, 2055.652, 2243.846 and 2.99.661 were highly expressed in sera of VSD children, and 11 proteins with m/z 2050.946, 9306.537, 7783.535, 9198.666, 2143.745, 4604.572, 7993.109, 2824.602, 2230.218, 2083.311 and 9360.675 were downregulated in sera of VSD children. Conclusion ProtcinChip technology is a effective tool for molecularly epidemiological study on VSD patients. The scroencd proteins are likely to bc the biomarkers in sera of VSD patients.
出处 《中国热带医学》 CAS 2007年第2期206-207,211,共3页 China Tropical Medicine
基金 广西教育基金资助项目(桂教科研200420)
关键词 室间隔缺损 儿童 血清标志物 蛋白质芯片技术 分子流行病学 Ventricular septal defect (VSD) Children Serum biomarkers ProteinChip technology Molecular epidemlology
  • 相关文献

参考文献10

  • 1仇小强,覃益敏,谢晓宇,刘芮荣,潘南海,彭如宽,张志勇,梁秋萍.1286例先天性心脏病患儿致病因素的调查研究[J].同济医科大学学报,1999,28(5):399-401. 被引量:39
  • 2Liotta LA,Ferrari M,Petricoin EF.Written in blood[J].Nature,2003,425(6961):905.
  • 3Thadikkaran L,Siegenthaler MA,Crettaz D,et al.Recent advances in blood-related proteomics[J].Proteomics,2005,5(12):3019 ~ 3034.
  • 4Boguski MS,McIntosh MW.Biomedical informatics for proteomics[J].Nature,2003,422(6928):233~227.
  • 5Seibert V,Ebert M and Buschmann T.Advances in clinical cancer proteomics:SELDI-ToF-mass spectrometry and biomarker discovery[J].Briefings in Functional Genomics and Proteomics,2005,4(1):16 ~ 26.
  • 6R(o)cken C,Ebert MPA,Roessner A.Proteomics in pathology,research and practice[J].Pathology,Research and Practice,2004,200(2):69 ~ 82.
  • 7Rosenblatt KP,Bryant-Greenwood P,Killian JK,et al.Serum proteomics in cancer diagnosis and management[J].Annual Review of Medicine,2004,55(1):97 ~ 112.
  • 8邓军,孔祥清,杨荣,盛燕辉,钱玲梅,周蕾,杨振文,孙伟,曹克将.室间隔缺损介入治疗前后可溶性细胞间黏附分子-1、P选择素、肌钙蛋白I的变化及意义[J].南京医科大学学报(自然科学版),2005,25(8):555-557. 被引量:8
  • 9Kiga C,Nakagawa T,Koizumi K,et al.Expression Patterns of Plasma Proteins in Spontaneously Diabetic Rats after Oral Administration of a Kampo Medicine,Hachimi -jio-gan,Using SELDI ProteinChip Platform[J].Biological & Pharmaceutical Bulletin,2005,28(6):1031 ~ 1037.
  • 10Malyarenko DI,Cooke WE,Adam BL,et al.Enhancement of Sensitivity and Resolution of Surface-Enhanced Laser Desorption/Ionization Time -of-Flight Mass Spectrometric Records for Serum Peptides Using Time -Series Analysis Techniques[J].Clinical Chemistry,2005,51 (1):65 ~74.

二级参考文献12

  • 1刘薇廷 周世瑜 等.上海市杨浦区先天性心脏病发病率及流行病学调查[J].中华儿科杂志,1989,27(5):262-262.
  • 2刘薇廷,中华儿科杂志,1989年,27卷,4期,262页
  • 3Boyle EM,Pohlman TH,Johnson MC,et al. Endothelial cell injury in cardiovascular surgery:the systemic inflammatory response [J ]. Ann Thorac Surg, 1997,63 (17):277-281.
  • 4Beata K, Jerzy S,Bogusl CW,et al. Activation of circulating platelets and platelet response to activating agents in children with cyanotic congenital heart disease:their relevance to palliative systemic-pulmonary shunt[J].International Journal of Cardiology, 2001, 79:49-59.
  • 5Hward SJ,Ballantyne CM,Shrrett AR,et al. Circulating adhesion molecules VCAM-1,ICAM-1,and E-selectin in carotid atherosclerosis and incident coronary heart disease case:the atherosclerosis risk in communities (ARIC)study[J]. Circulation, 1997,96(2):4219-4225.
  • 6Hitoshi H,Takashi M,Takeshi I,et al. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis [J].Thrombosis Research,2003,112:223-227.
  • 7Alan DM,Marc RB,Herbert BH,et al. In vivo tracking of platelets:Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function[J]. Medical Sciense, 1996,93:11877-11882.
  • 8龙振州.医学免疫学(第二版)[M].北京:人民卫生出版社,1997.73-75.
  • 9Serebruany VL, Cummings CC, Malinin Al, et al.Uniform platelet activation exists before stents implantation despite aspirin therapy [J]. Am Heart J,2001,142:611-616.
  • 10邵永丰,朱秉智,陈广明,陈亦江,陈亮,周元.体外循环瓣膜置换手术围术期血浆细胞粘附分子浓度的变化[J].南京医科大学学报(自然科学版),2001,21(3):246-248. 被引量:5

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部